Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study

Abstract Background Allergic rhinitis (AR) is a major non‐communicable disease that affects the health‐related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR + asthma) are lacking. Methods In this multicentre, cross‐sectional s...

Full description

Bibliographic Details
Main Authors: Subhabrata Moitra, Marzia Simoni, Sandra Baldacci, Sara Maio, Anna Angino, Patrizia Silvi, Giovanni Viegi, Stefania La Grutta, Franco Ruggiero, Gianni Bedini, Francesca Natali, Lorenzo Cecchi, Uwe Berger, Maria Prentovic, Amir Gamil, Nour Baïz, Michel Thibaudon, Samuel Monnier, Davide Caimmi, Luciana K. Tanno, Pascal Demoly, Simone Orlandini, Isabella Annesi‐Maesano
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Clinical and Translational Allergy
Subjects:
Online Access:https://doi.org/10.1002/clt2.12209
_version_ 1797895131922169856
author Subhabrata Moitra
Marzia Simoni
Sandra Baldacci
Sara Maio
Anna Angino
Patrizia Silvi
Giovanni Viegi
Stefania La Grutta
Franco Ruggiero
Gianni Bedini
Francesca Natali
Lorenzo Cecchi
Uwe Berger
Maria Prentovic
Amir Gamil
Nour Baïz
Michel Thibaudon
Samuel Monnier
Davide Caimmi
Luciana K. Tanno
Pascal Demoly
Simone Orlandini
Isabella Annesi‐Maesano
author_facet Subhabrata Moitra
Marzia Simoni
Sandra Baldacci
Sara Maio
Anna Angino
Patrizia Silvi
Giovanni Viegi
Stefania La Grutta
Franco Ruggiero
Gianni Bedini
Francesca Natali
Lorenzo Cecchi
Uwe Berger
Maria Prentovic
Amir Gamil
Nour Baïz
Michel Thibaudon
Samuel Monnier
Davide Caimmi
Luciana K. Tanno
Pascal Demoly
Simone Orlandini
Isabella Annesi‐Maesano
author_sort Subhabrata Moitra
collection DOAJ
description Abstract Background Allergic rhinitis (AR) is a major non‐communicable disease that affects the health‐related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR + asthma) are lacking. Methods In this multicentre, cross‐sectional study, patients with AR were screened and administered questionnaires of demographic characteristics and health conditions (symptoms/diagnosis of AR and asthma, disease severity level, and allergic conditions). HRQoL was assessed using a modified version of the RHINASTHMA questionnaire (30, ‘not at all bothered’ ‐ 150 ‘very much bothered’) and symptom control was evaluated by a modified version of the Control of Allergic Rhinitis/Asthma Test (CARAT) (0, ‘no control’ ‐ 30, ‘very high control’). Results Out of 643 patients with AR, 500 (78%) had asthma as a comorbidity, and 54% had moderate‐severe intermittent AR, followed by moderate‐severe persistent AR (34%). Compared to the patients with AR alone, patients with AR + asthma had significantly higher RHINASTHMA (e.g., median RHINASTHMA‐total score 48.5 vs. 84, respectively) and a significantly lower CARAT score (median CARAT‐total score 23 vs. 16.5, respectively). Upon stratifying asthma based on severity, AR patients with severe persistent asthma had worse HRQoL and control than those with mild persistent asthma. The association was significantly higher among non‐obese participants compared to obese ones, with RHINASTHMA‐upper symptoms score but not with CARAT. Conclusions Our observation of poorer HRQoL and symptoms control in AR patients with comorbid asthma supports the importance of a comprehensive approach for the management of AR in case of a comorbid allergic condition.
first_indexed 2024-04-10T07:20:30Z
format Article
id doaj.art-3adc0b0d9a78412797fc66d15e988155
institution Directory Open Access Journal
issn 2045-7022
language English
last_indexed 2024-04-10T07:20:30Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Clinical and Translational Allergy
spelling doaj.art-3adc0b0d9a78412797fc66d15e9881552023-02-24T10:01:15ZengWileyClinical and Translational Allergy2045-70222023-02-01132n/an/a10.1002/clt2.12209Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European studySubhabrata Moitra0Marzia Simoni1Sandra Baldacci2Sara Maio3Anna Angino4Patrizia Silvi5Giovanni Viegi6Stefania La Grutta7Franco Ruggiero8Gianni Bedini9Francesca Natali10Lorenzo Cecchi11Uwe Berger12Maria Prentovic13Amir Gamil14Nour Baïz15Michel Thibaudon16Samuel Monnier17Davide Caimmi18Luciana K. Tanno19Pascal Demoly20Simone Orlandini21Isabella Annesi‐Maesano22Division of Pulmonary Medicine & Alberta Respiratory Centre Department of Medicine University of Alberta Edmonton Alberta CanadaPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyPulmonary Environmental Epidemiology Unit CNR Institute of Clinical Physiology (IFC) Pisa ItalyCNR Institute of Translational Pharmacology (IFT) Palermo ItalyDepartment of Biology University of Pisa Pisa ItalyDepartment of Biology University of Pisa Pisa ItalyDepartment of Agrifood Production and Environmental Sciences University of Florence Florence ItalyCentre of Bioclimatology University of Florence Florence ItalyResearch Unit Aerobiology and Pollen Information Department of Oto‐Rhino‐Laryngology Medical University of Vienna Vienna AustriaResearch Unit Aerobiology and Pollen Information Department of Oto‐Rhino‐Laryngology Medical University of Vienna Vienna AustriaInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceReseau National de Surveillance Aerobiologique (RNSA) Brussieu FranceReseau National de Surveillance Aerobiologique (RNSA) Brussieu FranceInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceDepartment of Agrifood Production and Environmental Sciences University of Florence Florence ItalyInstitut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University Montpellier FranceAbstract Background Allergic rhinitis (AR) is a major non‐communicable disease that affects the health‐related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR + asthma) are lacking. Methods In this multicentre, cross‐sectional study, patients with AR were screened and administered questionnaires of demographic characteristics and health conditions (symptoms/diagnosis of AR and asthma, disease severity level, and allergic conditions). HRQoL was assessed using a modified version of the RHINASTHMA questionnaire (30, ‘not at all bothered’ ‐ 150 ‘very much bothered’) and symptom control was evaluated by a modified version of the Control of Allergic Rhinitis/Asthma Test (CARAT) (0, ‘no control’ ‐ 30, ‘very high control’). Results Out of 643 patients with AR, 500 (78%) had asthma as a comorbidity, and 54% had moderate‐severe intermittent AR, followed by moderate‐severe persistent AR (34%). Compared to the patients with AR alone, patients with AR + asthma had significantly higher RHINASTHMA (e.g., median RHINASTHMA‐total score 48.5 vs. 84, respectively) and a significantly lower CARAT score (median CARAT‐total score 23 vs. 16.5, respectively). Upon stratifying asthma based on severity, AR patients with severe persistent asthma had worse HRQoL and control than those with mild persistent asthma. The association was significantly higher among non‐obese participants compared to obese ones, with RHINASTHMA‐upper symptoms score but not with CARAT. Conclusions Our observation of poorer HRQoL and symptoms control in AR patients with comorbid asthma supports the importance of a comprehensive approach for the management of AR in case of a comorbid allergic condition.https://doi.org/10.1002/clt2.12209allergy treatmentCARATfood allergypollenRHINASTHMArhinitis
spellingShingle Subhabrata Moitra
Marzia Simoni
Sandra Baldacci
Sara Maio
Anna Angino
Patrizia Silvi
Giovanni Viegi
Stefania La Grutta
Franco Ruggiero
Gianni Bedini
Francesca Natali
Lorenzo Cecchi
Uwe Berger
Maria Prentovic
Amir Gamil
Nour Baïz
Michel Thibaudon
Samuel Monnier
Davide Caimmi
Luciana K. Tanno
Pascal Demoly
Simone Orlandini
Isabella Annesi‐Maesano
Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
Clinical and Translational Allergy
allergy treatment
CARAT
food allergy
pollen
RHINASTHMA
rhinitis
title Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
title_full Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
title_fullStr Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
title_full_unstemmed Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
title_short Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
title_sort symptom control and health related quality of life in allergic rhinitis with and without comorbid asthma a multicentre european study
topic allergy treatment
CARAT
food allergy
pollen
RHINASTHMA
rhinitis
url https://doi.org/10.1002/clt2.12209
work_keys_str_mv AT subhabratamoitra symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT marziasimoni symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT sandrabaldacci symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT saramaio symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT annaangino symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT patriziasilvi symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT giovanniviegi symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT stefanialagrutta symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT francoruggiero symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT giannibedini symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT francescanatali symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT lorenzocecchi symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT uweberger symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT mariaprentovic symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT amirgamil symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT nourbaiz symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT michelthibaudon symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT samuelmonnier symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT davidecaimmi symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT lucianaktanno symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT pascaldemoly symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT simoneorlandini symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy
AT isabellaannesimaesano symptomcontrolandhealthrelatedqualityoflifeinallergicrhinitiswithandwithoutcomorbidasthmaamulticentreeuropeanstudy